123
Views
17
CrossRef citations to date
0
Altmetric
Review

Botulinum toxin type A treatment to the upper face: retrospective analysis of daily practice

, , , , , , , , , , , , & show all
Pages 53-58 | Published online: 08 Jun 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Tatjana Pavicic, Welf Prager, Markus Klöppel, Simon Ravichandran & Olivier Galatoire. (2015) IncobotulinumtoxinA use in aesthetic indications in daily practice: a European multicenter, noninterventional, retrospective study. Clinical, Cosmetic and Investigational Dermatology 8, pages 135-142.
Read now
Byung Wook Kim, Gyeong-Hun Park, Woo Jin Yun, Nark Kyoung Rho, Kyoung Ae Jang, Chong Hyun Won, Sung Eun Chang, Sun Ju Chung & Mi Woo Lee. (2014) Adverse events associated with botulinum toxin injection: A multidepartment, retrospective study of 5310 treatments administered to 1819 patients. Journal of Dermatological Treatment 25:4, pages 331-336.
Read now
Andy Pickett. (2013) Reviews of botulinum toxin products in aesthetic use must be accurate, clear and avoid speculation. Clinical Pharmacology: Advances and Applications 5, pages 149-152.
Read now
Welf Prager. (2013) Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines. Clinical Pharmacology: Advances and Applications 5, pages 39-52.
Read now

Articles from other publishers (13)

Anthony V. Benedetto. 2020. Periorbital Rejuvenation. Periorbital Rejuvenation 83 117 .
Christina Marciniak, Michael C. Munin, Allison Brashear, Bruce S. Rubin, Atul T. Patel, Jaroslaw Slawek, Angelika Hanschmann, Reinhard Hiersemenzel & Elie P. Elovic. (2018) IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study. Advances in Therapy 36:1, pages 187-199.
Crossref
Patrick TrevidicSimon A. ConnollyBernard BiwerBarbara Ellers-LenzLaura S. HarringtonPhilippe KestemontErnst M. NoahGerhard Sattler, Petra WeissenbergerMartina Kerscher. (2017) IncobotulinumtoxinA Is an Effective and Well-Tolerated Treatment for Upper Facial Lines: Results From an Open-Label Extension Period of a Phase III Study. Dermatologic Surgery 43:3, pages S285-S292.
Crossref
Ulrich Kühne & Matthias Imhof. 2017. Botulinum Toxins. Botulinum Toxins 79 95 .
Cerrene N. Giordano, Seth L. Matarasso & David M. Ozog. (2017) Injectable and topical neurotoxins in dermatology. Journal of the American Academy of Dermatology 76:6, pages 1013-1024.
Crossref
Clement Qaqish. (2016) Botulinum Toxin Use in the Upper Face. Atlas of the Oral and Maxillofacial Surgery Clinics 24:2, pages 95-103.
Crossref
Martina Kerscher, Berthold Rzany, Welf Prager, Catriona Turnbull, Patrick Trevidic & Christopher Inglefield. (2015) Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Upper Facial Lines. Dermatologic Surgery 41:10, pages 1149-1157.
Crossref
Anthony J. Wilson, Bianca C. Chin, Vivian M. Hsu, Michael N. Mirzabeigi & Ivona Percec. (2015) Digital Image Correlation. Plastic and Reconstructive Surgery 135:5, pages 869e-876e.
Crossref
Benjamin P. Erickson, Wendy W. Lee, Joel Cohen & Lisa D. Grunebaum. (2015) The Role of Neurotoxins in the Periorbital and Midfacial Areas. Facial Plastic Surgery Clinics of North America 23:2, pages 243-255.
Crossref
Meike Streker, Stefanie Luebberding, Nils Krueger, Laura Harrington & Martina Kerscher. (2015) Patient-Reported Outcomes After IncobotulinumtoxinA Treatment for Upper Facial Wrinkles. Dermatologic Surgery 41:Supplement 1, pages S29-S38.
Crossref
Doris Hexsel, Mariana Soirefmann, Manoela D. Porto, Carolina Siega, Juliana Schilling-Souza & Ticiana C. Rodrigues. (2015) Fields of Muscular and Anhidrotic Effects of 2 Botulinum Toxin-A Commercial Preparations. Dermatologic Surgery 41:Supplement 1, pages S110-S118.
Crossref
Matthias Imhof, Maurizio Podda & Boris Sommer. (2013) S1 guideline aesthetic botulinum toxin therapy. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 11:10, pages e1-e13.
Crossref
Welf Prager & Thomas Rappl. (2012) Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines. Journal of Cosmetic Dermatology 11:4, pages 267-271.
Crossref